Search
for
Sort by
Research 391–420 of 1000+
- The post-finasteride syndrome: possible etiological mechanisms and symptoms
- Simultaneous spectrophotometric determination of finasteride and tadalafil in recently FDA approved Entadfi™ capsules
- Dutasteride Improves Nocturia but Does Not Lead to Better Sleep: Results from the REDUCE Clinical Trial
- Safety and efficacy of advanced and targeted acid α-glucosidase (AT-GAA) (ATB200/AT2221) in ERT-switch nonambulatory patients with Pompe disease: preliminary results from the ATB200-02 trial
- WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH
- Why Odds Ratios Can Be Tricky Statistics
- Complications of cataract surgery in Wistar rats undergoing treatment with tamsulosin
- Finasteride use during pregnancy and early neonatal outcome: a case report
- Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system
- Blockade of Androgen Markers Using a Novel Betasitosterol, Thioctic Acid and Carnitine-containing Compound in Prostate and Hair Follicle Cell-based Assays
- 5ARIs and PSA: Evidences
- Regarding prostate-specific antigen: let's not shoot the messenger
- Homologous recombination induced by doxazosin mesylate and saw palmetto in the <i>Drosophila</i> wing‐spot test
- 5α-Reductase Inhibitors – The Finasteride Story
- Doxazosin and finasteride alone or in combination: the PREDICT study
- Clinical use of 5α-reductase inhibitors
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- GYNECOMASTIA AFTER FINASTERIDE THERAPY
- The synthesis of (−)-4-methyl-8-chloro-trans-1,2,3,4,4a,5,6,10b-octahydrobenzo-[f]-quinolin-3-one-[3-14C] (LY300502-14C]) via a circuitous route
- HPLC characterization, molecular docking, QSAR and molecular dynamics simulation of Alstonia boonei phytochemical analogs as potent 5-alpha reductase inhibitors
- Scientific Evaluation of A Unani Pharmacopoeia-Based Formulation on BPH in Animal Model
- Oral Presentations: Abstracts of the Urological Society of Australia and New Zealand Annual Scientific Meeting, 25–28 February 2023, Melbourne, Australia
- Lipid Profile and 5α-Reductase Inhibition Activity of Proprietary Ultrahigh-Pressure Supercritical Carbon Dioxide and Hexane Saw Palmetto Extracts
- Potential roles of FGF5 as a candidate therapeutic target in prostate cancer.
- 5‐Alpha reductase inhibitor related litigation: A legal database review
- Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis
- Medical Therapies for Treatment of BPH: Special Considerations in Elderly Men
- Acute gross hematuria: etiology and management
- Targeting a fibrotic bottleneck may provide an opening in the treatment of LUTS
- Pharmacophore and Atom Based 3D QSAR Studies on the Novel 5-Alpha-Reductase Inhibitors